# Xpert MTB/XDR Clinical Evaluation Trial

> **NCT03728725** · — · COMPLETED · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 710 (actual)

## Conditions studied

- Tuberculosis, Pulmonary
- Tuberculosis, Multidrug-Resistant

## Interventions

- **DEVICE:** Cepheid Gene Xpert MTB/XDR

## Key facts

- **NCT ID:** NCT03728725
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-11
- **Primary completion:** 2020-08-18
- **Final completion:** 2020-08-18
- **Target enrollment:** 710 (ACTUAL)
- **Last updated:** 2021-05-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03728725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03728725, "Xpert MTB/XDR Clinical Evaluation Trial". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03728725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*